Emmaus Life Sciences Inc (EMMA)
0.105
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Emmaus Life Sciences Total Assets (Quarterly): 47.45M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 47.45M |
| June 30, 2023 | 50.29M |
| March 31, 2023 | 48.95M |
| December 31, 2022 | 48.22M |
| September 30, 2022 | 42.20M |
| June 30, 2022 | 45.99M |
| March 31, 2022 | 51.49M |
| December 31, 2021 | 56.73M |
| September 30, 2021 | 60.06M |
| June 30, 2021 | 63.28M |
| March 31, 2021 | 62.22M |
| December 31, 2020 | 59.54M |
| September 30, 2020 | 59.94M |
| June 30, 2020 | 56.25M |
| March 31, 2020 | 65.99M |
| December 31, 2019 | 59.46M |
| September 30, 2019 | 56.48M |
| June 30, 2019 | 4.348M |
| March 31, 2019 | 3.141M |
| December 31, 2018 | 3.406M |
| September 30, 2018 | 5.152M |
| June 30, 2018 | 4.751M |
| March 31, 2018 | 4.532M |
| December 31, 2017 | 4.543M |
| September 30, 2017 | 6.096M |
| Date | Value |
|---|---|
| June 30, 2017 | 1.214M |
| March 31, 2017 | 2.430M |
| December 31, 2016 | 2.472M |
| September 30, 2016 | 0.5121M |
| June 30, 2016 | 0.7064M |
| March 31, 2016 | 0.6599M |
| December 31, 2015 | 0.9243M |
| September 30, 2015 | 0.5671M |
| June 30, 2015 | 0.2731M |
| March 31, 2015 | 0.4537M |
| December 31, 2014 | 0.5071M |
| September 30, 2014 | 1.336M |
| June 30, 2014 | 0.1973M |
| March 31, 2014 | 0.9242M |
| December 31, 2013 | 0.7496M |
| September 30, 2013 | 1.402M |
| June 30, 2013 | 0.8313M |
| March 31, 2013 | 0.8821M |
| December 31, 2012 | 0.9098M |
| September 30, 2012 | 0.1253M |
| June 30, 2012 | 0.1853M |
| March 31, 2012 | 0.7049M |
| December 31, 2011 | 0.4618M |
| September 30, 2011 | 0.37M |
| June 30, 2011 | 1.363M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.348M
Minimum
Jun 2019
65.99M
Maximum
Mar 2020
52.16M
Average
56.37M
Median
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 19.38M |
| Perspective Therapeutics Inc | 97.89M |
| Protalix BioTherapeutics Inc | 84.43M |
| Electromed Inc | 46.96M |
| Armata Pharmaceuticals Inc | 98.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 83.78M |
| Shareholders Equity (Quarterly) | -36.33M |
| Debt to Equity Ratio | -0.8928 |
| Current Ratio | 0.152 |
| Net Debt Paydown Yield | -1.75% |